Mobilization of Endothelial Progenitor Cells and Aspirin

• Status: Recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Aspirin at doses used during acute myocardial infarction may inhibit the mobilization of endothelial progenitor cells (EPCs).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ottawa Heart Institute Research Corporation
• Treatments: Aspirin; Ethanol

Criteria

Inclusion Criteria:

1. Patients who have been selected to undergo alcohol septal ablation for hypertrophic obstructive cardiomyopathy based on clinical need

2. Age >18 years, <80 years

Exclusion Criteria:

1. Patients with known allergy to aspirin

2. Inability or refusal to consent to participate in the study

3. Patients who are on non-steroidal anti-inflammatory drugs and cannot be stopped for the duration of the study